empagliflozin glp 1 SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application The Role of GLP-1, DPP-4,

Three of our portfolio companies are helping define what that looks like: FlyteHealth, OpenLoop, and Tenovi, an Inc

Perfect for mornings, workouts, or whenever you need a clean lift no crash, no jitters

What began in the metabolic health space is now influencing how consumers shop, eat, and live.

GLP-1 medications like semaglutide and tirzepatide are FDA-approved treatments that support sustainable weight loss by regulating appetite, improving insulin sensitivity, and addressing metabolic challenges.

Updated for 2026 with CMS-0057-F rule, Medicare GLP-1 Bridge program, MFN pricing deals, oral Wegovy approval, and AHIP reform pledges.

The adoption of anti-obesity medications (AOMs), such as GLP-1 receptor agonists, continues to accelerate globally, with spending projected to reach nearly $200 billion by 2029 (according to the IQVIA Institute for Human Data Science)